Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Beata Osuch is active.

Publication


Featured researches published by Beata Osuch.


Gynecological Endocrinology | 2010

Expression of vascular endothelial growth factor mRNA in human leiomyomas.

Anna Lewicka; Beata Osuch; Krzysztof Cendrowski; Jolanta Zegarska; Jerzy Stelmachów

Aim. Growth factors play a major role in the pathogenesis of uterine myomas. The aim of this study was to evaluate vascular endothelial growth factor (VEGF) mRNA expression during leiomyoma growth at different phases of the menstrual cycle with RT-PCR. Method. We studied 56 patients: 43 with myomas, 13 with healthy myometriums. In patients with myomas (secretory phase), VEGF expression was 2.82 times higher than in control patients (p < 0.05). In patients with myomas (phase I), VEGF expression was 2.53 times higher (p < 0.05) than in control patients. For all patients with myomas, those who were in menopause had 1.52 times higher VEGF expression than those who menstruated. For patients with healthy myometriums, those who were in menopause had 1.97 times higher VEGF expression than those who menstruated. A comparison of all the patients in menopause revealed that VEGF expression was 2.03-fold higher in those with myomas than in those with healthy myometriums. Conclusion. We observed the highest VEGF mRNA expression in women with myomas who were in menopause. Among menstruating patients, VEGF expression was significantly higher in those with myomas compared to those with a healthy myometrium. This suggested that VEGF may play a significant role in the pathogenesis of uterine myomas.


Photodiagnosis and Photodynamic Therapy | 2017

Photodynamic therapy in the treatment of vulvar lichen sclerosus

Agnieszka Maździarz; Beata Osuch; Magdalena Kowalska; Agnieszka Nalewczyńska; Beata Śpiewankiewicz

BACKGROUND Vulvar lichen sclerosus is a chronic and incurable disease that causes various unpleasant symptoms and serious consequences. OBJECTIVE The purpose of the study was to assess the effectiveness of photodynamic therapy in the treatment of vulvar lichen sclerosus. METHODS Participants in the study included 102 female patients aged 19-85 suffer from vulvar lichen sclerosus. The patients underwent photodynamic therapy (PDT). In the course of PDT the 5% 5- aminolevulinic acid was used in gel form. The affected areas were irradiated with a halogenic lamp PhotoDyn 501 (590-760nm) during a 10-min radiation treatment. The treatment was repeated weekly for 10 weeks. RESULT PDT has brought about a good therapeutic effect (complete or partial clinical remission), with 87.25% improvement rate in patients suffering from lichen sclerosus. The greatest vulvoscopic response was observed in the reduction of subepithelial ecchymoses and teleangiectasia (78.95%), and the reduction of erosions and fissures (70.97%). A partial remission of lichenification with hyperkeratosis was observed in 51.61% of cases. The least response was observed in the atrophic lesions reduction (improvement in 37.36% of cases). CONCLUSION Our patients suffering from vulvar lichen sclerosus demonstrated positive responses to photodynamic therapy and the treatment was well tolerated. Photodynamic therapy used to treat lichen sclerosus yields excellent cosmetic results.


Current Gynecologic Oncology | 2013

Zalecenia postępowania diagnostyczno-terapeutycznego u chorych na mięsaki macicy

Piotr Rutkowski; Beata Śpiewankiewicz; Hanna Koseła; Tomasz Świtaj; Beata Osuch; Katarzyna Wiater; Sławomir Falkowski; Agnieszka Maździarz

1 Klinika Nowotworów Tkanek Miękkich, Kości i Czerniaków, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie w Warszawie. Kierownik: prof. dr hab. n. med. Piotr Rutkowski 2 Klinika Ginekologii Onkologicznej, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie w Warszawie. Kierownik: prof. dr hab. n. med. Beata Śpiewankiewicz Correspondence to: Klinika Nowotworów Tkanek Miękkich, Kości i Czerniaków, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, ul. Roentgena 5, 02-781 Warszawa, tel.: 22 643 93 75, e-mail: [email protected] Source of financing: Department own sources


Annals of Agricultural and Environmental Medicine | 2017

New directions in cervical cancer prophylaxis worldwide and in Poland – Case study of the Polish rural female population

Agnieszka Maździarz; Jerzy Wyględowski; Beata Osuch; Beata Jagielska; Beata Śpiewankiewicz

INTRODUCTION Cervical cancer is one of the most frequent malignant neoplasms in females. Such neoplasms can be almost completely eliminated by means of adequate primary and secondary prophylaxis. The most developed countries focus their attention on the improvement of prophylaxis systems, test quality, and efficacy improvement, as well as on the expansion of the primary prophylaxis. In Poland, the discussions focus on the improvement of the malfunctioning population programme. OBJECTIVE Drawing on recent research findings, the article presents current Polish and global recommendations with regard to screening tests for cervical cancer. The results of the Population Programme of Prophylaxis and Early Detection of Cervical Cancer are discussed in the context of current trends of healthy behaviour among women inhabiting rural areas. DESCRIPTION OF THE STATE OF KNOWLEDGE In the future, it will be relevant to increase the number of human papillary virus (HPV) tests as part of the prophylaxis programme, especially among the high risk patient group. In particular, there is a necessity to increase the number of vaccinations among young women, especially before the beginning of their sexual activity, as well as to establish new strategies of secondary prophylaxis in this group. At present, women who had been vaccinated should undergo routine screening. In Poland, the report based on SIMP registry (IT System of Prophylaxis Monitoring), shows that only 27% of the 3.3 million of invited women participated in the cytology tests. The data analysis shows that women living in rural areas more often respond and participate in the tests, compared to women living in the cities (39.3% vs. 16.8%).


Current Gynecologic Oncology | 2013

Practical considerations for intraoperative anesthesia in patients undergoing surgery in combination with hyperthermic intraperitoneal perfusion chemotherapy – a series of 60 cases

Małgorzata Symonides; Marta Łuniewska; Marta Fortuna; Beata Osuch; Magdalena Kowalska; Jerzy Kuśnierz; Beata Śpiewankiewicz

Uwagi praktyczne do śródoperacyjnej anestezji u pacjentów operowanych z zastosowaniem dootrzewnowej perfuzyjnej chemioterapii w warunkach hipertermii – seria 60 przypadków Practical considerations for intraoperative anesthesia in patients undergoing surgery in combination with hyperthermic intraperitoneal perfusion chemotherapy – a series of 60 cases Практические замечания по интраоперационной анестезии у пациентов оперированных с применением внутрибрюшинной перфузионной химиотерапии в условиях гипертермии – серия 60 случаев


Current Gynecologic Oncology | 2013

Wstępna ocena przydatności dootrzewnowej perfuzyjnej chemioterapii w warunkach hipertermii (HIPEC) u chorych z nowotworowym rozsiewem wewnątrzotrzewnowym

Beata Śpiewankiewicz; Beata Osuch; Jerzy Kuśnierz; Małgorzata Symonides; Malwina Smorczewska


Journal of Reproductive Medicine | 2009

Therapeutic management of acoustic neurinoma during twin pregnancy: a case report.

Ewa Kurowska-Mroczek; Miroslaw Zabek; Beata Osuch; Jerzy Stelmachów


Current Gynecologic Oncology | 2015

Analiza powikłań pooperacyjnych wymagających ponownego zabiegu w materiale Kliniki Ginekologii Onkologicznej Centrum Onkologii w Warszawie z lat 2009–2014

Jerzy Wyględowski; Beata Osuch; Agnieszka Maździarz; Beata Śpiewankiewicz


Current Gynecologic Oncology | 2014

Wybrane poglądy na postępowanie diagnostyczne i terapeutyczne w przypadku kobiet w ciąży – ze szczególnym uwzględnieniem nowotworów złośliwych jajnika

Beata Osuch; Agnieszka Maździarz; Anna Skrzypczak; Beata Jagielska; Beata Śpiewankiewicz


Current Gynecologic Oncology | 2014

Rak piersi współistniejący z ciążą

Anna Skrzypczyk-Ostaszewicz; Beata Jagielska; Beata Spiewankiewicz; Beata Osuch

Collaboration


Dive into the Beata Osuch's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jerzy Stelmachów

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomasz Świtaj

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna Lewicka

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Jolanta Zegarska

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Krzysztof Cendrowski

Medical University of Warsaw

View shared research outputs
Researchain Logo
Decentralizing Knowledge